These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17139568)

  • 1. Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium.
    Harris RE
    IDrugs; 2006 Dec; 9(12):834-6. PubMed ID: 17139568
    [No Abstract]   [Full Text] [Related]  

  • 2. IBC's 6th Annual Conference on Angiogenesis: Novel Therapeutic Developments.
    Mousa SA
    Expert Opin Investig Drugs; 2001 Feb; 10(2):387-91. PubMed ID: 11424887
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiangiogenesis: new frontiers in therapeutic development.
    LaMontagne KR
    Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.
    O'Reilly MS
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S64-6. PubMed ID: 17848299
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor.
    Kim JY; Chung SW; Kim SY; Byun Y
    Pharm Res; 2015 Jul; 32(7):2318-27. PubMed ID: 25585956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenesis and antiangiogenesis in intraocular tumors].
    Macovei L
    Oftalmologia; 2010; 54(4):24-6. PubMed ID: 21516858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
    Grothey A; Ellis LM
    Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis: novel and basic science insights and human therapy - keystone symposium.
    Iruela-Arispe L
    IDrugs; 2004 Feb; 7(2):111-3. PubMed ID: 15057650
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic inhibition of angiogenesis.
    Zhang HT; Bicknell R
    Mol Biotechnol; 2003 Oct; 25(2):185-200. PubMed ID: 14526126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited.
    Loges S; Mazzone M; Hohensinner P; Carmeliet P
    Cancer Cell; 2009 Mar; 15(3):167-70. PubMed ID: 19249675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and not cyclooxygenase 2 promotes endothelial cell viability in the pancreatic tumor microenvironment.
    Toomey DP; Manahan E; McKeown C; Rogers A; McMillan H; Geary M; Conlon KC; Murphy JF
    Pancreas; 2010 Jul; 39(5):595-603. PubMed ID: 20118820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in colorectal cancer: therapeutic implications and future directions.
    Allen J; Bergsland EK
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1087-119, ix. PubMed ID: 15474337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 16. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor: biology and therapeutic applications.
    Ho QT; Kuo CJ
    Int J Biochem Cell Biol; 2007; 39(7-8):1349-57. PubMed ID: 17537667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targeting: targeting angiogenesis in solid tumors.
    Soria JC; Fayette J; Armand JP
    Ann Oncol; 2004; 15 Suppl 4():iv223-7. PubMed ID: 15477311
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiogenesis as a therapeutic target in cancer.
    Kumaran G; Clamp AR; Jayson GC
    Clin Med (Lond); 2008 Aug; 8(4):455-8. PubMed ID: 18724620
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents.
    Limaverde-Sousa G; Sternberg C; Ferreira CG
    Cancer Treat Rev; 2014 May; 40(4):548-57. PubMed ID: 24360358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.